Sera Prognostics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SERA research report →
About the company
Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the PreTRM test, is a blood-based biomarker assay specifically designed to predict the likelihood of spontaneous preterm birth in singleton pregnancies where no symptoms are yet present.
- CEO
- Zhenya Lindgardt
- IPO
- 2021
- Employees
- 63
- HQ
- Salt Lake City, UT, US
Price Chart
- Market Cap
- $76.38M
- P/E
- -3.08
- P/S
- 1340.03
- P/B
- 1.49
- EV/EBITDA
- -2.39
- Div Yield
- 0.00%
- Gross Margin
- -191.23%
- Op Margin
- -64235.09%
- Net Margin
- -56385.96%
- ROE
- -41.02%
- ROIC
- -52.21%
- Revenue
- $81.00K · 5.19%
- Net Income
- $-31,928,000 · 2.95%
- EPS
- $-0.67 · 32.32%
- Op Income
- $-36,504,000
- FCF YoY
- -72.33%
- 52W High
- $3.95
- 52W Low
- $1.56
- 50D MA
- $1.93
- 200D MA
- $2.63
- Beta
- 0.94
- Avg Volume
- 50.84K
Get TickerSpark's AI analysis on SERA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 1, 26 | Capone Mark Christopher | other | 0 |
| Jun 11, 26 | Anderson Dyaarl Lee Jr. | sell | 4,739 |
| Jun 11, 26 | Aerts Austin | sell | 2,037 |
| Jun 11, 26 | Lindgardt Zhenya | sell | 6,990 |
| Jun 11, 26 | Inglis Tiffany Eul Davis | sell | 362 |
| Jun 11, 26 | Jackson Benjamin | sell | 2,179 |
| Jun 9, 26 | Lindgardt Zhenya | sell | 20,755 |
| Jun 9, 26 | Aerts Austin | sell | 5,440 |
| Jun 8, 26 | Lawrence Sandra AJ | sell | 1,560 |
| Jun 4, 26 | Elliott Jeffrey Thomas | other | 0 |
Our SERA coverage
Recent articles, reports, and earnings notes.
No research on SERA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SERA report →Similar companies
Peers in the same neighborhood.